The Penny Bank

[FullGlass]

Genesis Biopharma GNBP had some interesting points in the 10 K:

During 2012 and early 2013, they intend to work with their manufacturing partner, Lonza Walkersville to develop an FDA compliant manufacturing process for Contego, with the goal being to submit our investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) in late 2013.

GNBP will then seek allowance to proceed with a pivotal clinical trials for Contego for the treatment of Stage IV metastatic melanoma patients who are refractory to all FDA approved therapies for treatment of the disease.

Very cool stuff potentially coming down the pipe IMO